{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:54:35Z","timestamp":1790985275003,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012416","name":"Bundesministerium f\u00fcr Digitalisierung und Wirtschaftsstandort","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010132","name":"\u00d6sterreichische Nationalstiftung f\u00fcr Forschung, Technologie und Entwicklung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006012","name":"Christian Doppler Forschungsgesellschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006012","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.esmoop.2023.101200","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T20:42:54Z","timestamp":1679949774000},"page":"101200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Clinical risk factors for ascites in metastatic pancreatic cancer"],"prefix":"10.1016","volume":"8","author":[{"given":"J.M.","family":"Berger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Alany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Puhr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Berchtold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Scheiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.W.","family":"Prager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.S.","family":"Berghoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Preusser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.S.","family":"Bergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.esmoop.2023.101200_bib1","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/annonc\/mdl499","article-title":"Pattern and prognostic factors in patients with malignant ascites: a retrospective study","volume":"18","author":"Ayantunde","year":"2007","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.esmoop.2023.101200_bib2","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/1097-0142(19890801)64:3<753::AID-CNCR2820640330>3.0.CO;2-Y","article-title":"Malignant ascites of unknown origin","volume":"64","author":"Ringenberg","year":"1989","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.esmoop.2023.101200_bib3","first-page":"38","article-title":"Clinical features and management of malignant ascites","volume":"41","author":"Malik","year":"1991","journal-title":"J\u00a0Pak Med Assoc"},{"issue":"7","key":"10.1016\/j.esmoop.2023.101200_bib4","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1002\/1097-0142(19930401)71:7<2377::AID-CNCR2820710732>3.0.CO;2-H","article-title":"Malignant ascites. A comparison of peritoneovenous shunting and nonoperative management","volume":"71","author":"Gough","year":"1993","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.esmoop.2023.101200_bib5","first-page":"47","article-title":"A\u00a0new approach to the management of malignant ascites; a permanently implanted abdominal drain","volume":"16","author":"Belfort","year":"1990","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.esmoop.2023.101200_bib6","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/0016-5085(92)91520-E","article-title":"Mobilization of malignant ascites with diuretics is dependent on ascitic fluid characteristics","volume":"103","author":"Pockros","year":"1992","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.esmoop.2023.101200_bib7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1699-0463.1953.tb04805.x","article-title":"Pathogenesis of ascites in peritoneal carcinomatosis","volume":"33","author":"Holm-Nielsen","year":"1953","journal-title":"Acta Pathol Microbiol Scand"},{"issue":"8","key":"10.1016\/j.esmoop.2023.101200_bib8","first-page":"1663","article-title":"The role of lymphatic obstruction in the formation of ascites in a murine ovarian carcinoma","volume":"32","author":"Feldman","year":"1972","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.esmoop.2023.101200_bib9","first-page":"2631","article-title":"Pathogenesis of malignant ascites formation: initiating events that lead to fluid accumulation","volume":"53","author":"Nagy","year":"1993","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.esmoop.2023.101200_bib10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10434-999-0373-0","article-title":"Markedly elevated levels of vascular endothelial growth factor in malignant ascites","volume":"6","author":"Zebrowski","year":"1999","journal-title":"Ann Surg Oncol"},{"issue":"suppl 1","key":"10.1016\/j.esmoop.2023.101200_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1634\/theoncologist.5-suppl_1-45","article-title":"Targeting vascular endothelial growth factor blockade: ascites and pleural effusion formation","volume":"5","author":"Verheul","year":"2000","journal-title":"Oncologist"},{"issue":"15","key":"10.1016\/j.esmoop.2023.101200_bib12","first-page":"5721","article-title":"Vascular endothelial growth factor-trap decreases tumor burden, inhibits ascites, and causes dramatic vascular remodeling in an ovarian cancer model","volume":"9","author":"Byrne","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.esmoop.2023.101200_bib13","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.4049\/jimmunol.163.11.6251","article-title":"Identification of an IL-10-producing HLA-DR-negative monocyte subset in the malignant ascites of patients with ovarian carcinoma that inhibits cytokine protein expression and proliferation of autologous T cells","volume":"163","author":"Loercher","year":"1999","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"10.1016\/j.esmoop.2023.101200_bib14","article-title":"Circulating CD14(high) CD16(low) intermediate blood monocytes as a biomarker of ascites immune status and ovarian cancer progression","volume":"8","author":"Prat","year":"2020","journal-title":"J\u00a0Immunother Cancer"},{"issue":"4","key":"10.1016\/j.esmoop.2023.101200_bib15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4240\/wjgs.v4.i4.87","article-title":"Malignant ascites: a review of prognostic factors, pathophysiology and therapeutic measures","volume":"4","author":"Sangisetty","year":"2012","journal-title":"World J Gastrointest Surg"},{"issue":"3","key":"10.1016\/j.esmoop.2023.101200_bib16","doi-asserted-by":"crossref","first-page":"114.e9","DOI":"10.1016\/j.urolonc.2016.10.023","article-title":"Determinants and prognostic implications of malignant ascites in metastatic papillary renal cancer","volume":"35","author":"Sidana","year":"2017","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2023.101200_bib17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0002-9343(56)90004-3","article-title":"Portal hypertension due to chronic occlusion of the extrahepatic portion of the portal vein: its relation to ascites","volume":"21","author":"Baggenstoss","year":"1956","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.esmoop.2023.101200_bib18","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/0016-5085(88)90441-6","article-title":"Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites","volume":"94","author":"Llach","year":"1988","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.esmoop.2023.101200_bib19","article-title":"Ascites and resistance to immune checkpoint inhibition in dMMR\/MSI-H metastatic colorectal and gastric cancers","volume":"10","author":"Fuc\u00e0","year":"2022","journal-title":"J\u00a0Immunother Cancer"},{"issue":"suppl 5","key":"10.1016\/j.esmoop.2023.101200_bib20","doi-asserted-by":"crossref","first-page":"v56","DOI":"10.1093\/annonc\/mdv295","article-title":"Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Ducreux","year":"2015","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.esmoop.2023.101200_bib21","article-title":"The ALBI score: from liver function in patients with HCC to a general measure of liver function","volume":"4","author":"Toyoda","year":"2022","journal-title":"JHEP Rep"},{"issue":"4","key":"10.1016\/j.esmoop.2023.101200_bib22","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0895-4356(00)00314-0","article-title":"Adjusting for multiple testing - when and how?","volume":"54","author":"Bender","year":"2001","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"2","key":"10.1016\/j.esmoop.2023.101200_bib23","doi-asserted-by":"crossref","first-page":"dju413","DOI":"10.1093\/jnci\/dju413","article-title":"nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: long-term survival from a phase III trial","volume":"107","author":"Goldstein","year":"2015","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"19","key":"10.1016\/j.esmoop.2023.101200_bib24","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.esmoop.2023.101200_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10147-012-0396-6","article-title":"Malignant ascites: pathophysiology and treatment","volume":"18","author":"Cavazzoni","year":"2013","journal-title":"Int J Clin Oncol"},{"issue":"3","key":"10.1016\/j.esmoop.2023.101200_bib26","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/MPA.0000000000000290","article-title":"Pancreatic cancer with malignant ascites: clinical features and outcomes","volume":"44","author":"Takahara","year":"2015","journal-title":"Pancreas"},{"issue":"1","key":"10.1016\/j.esmoop.2023.101200_bib27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1477-7819-4-16","article-title":"Prognostic significance of new onset ascites in patients with pancreatic cancer","volume":"4","author":"Zervos","year":"2006","journal-title":"World J Surg Oncol"},{"issue":"4","key":"10.1016\/j.esmoop.2023.101200_bib28","first-page":"360","article-title":"Pancreas adenocarcinoma: ascites, clinical manifestations, and management implications","volume":"15","author":"Hicks","year":"2016","journal-title":"Clin Colorectal Cancer"},{"issue":"39","key":"10.1016\/j.esmoop.2023.101200_bib29","doi-asserted-by":"crossref","first-page":"10936","DOI":"10.3748\/wjg.v21.i39.10936","article-title":"Evaluation and treatment of malignant ascites secondary to gastric cancer","volume":"21","author":"Maeda","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.esmoop.2023.101200_bib30","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0748-7983(96)80009-6","article-title":"Malignant ascites: a 2-year review from a teaching hospital","volume":"22","author":"Parsons","year":"1996","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"10.1016\/j.esmoop.2023.101200_bib31","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1111\/liv.14977","article-title":"Portal hypertension and hepatocellular carcinoma: des liaisons dangereuses\u2026","volume":"41","author":"Allaire","year":"2021","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.esmoop.2023.101200_bib32","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.mayocp.2018.12.020","article-title":"Portal hypertension and related complications: diagnosis and management","volume":"94","author":"Simonetto","year":"2019","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"10.1016\/j.esmoop.2023.101200_bib33","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.4103\/jcrt.JCRT_500_20","article-title":"Portal hypertension caused by pancreatic cancer: multidetector computed tomography diagnosis and multivariate analysis of variceal hemorrhage","volume":"16","author":"Liu","year":"2020","journal-title":"J\u00a0Cancer Res Ther"},{"issue":"18","key":"10.1016\/j.esmoop.2023.101200_bib34","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.3748\/wjg.v13.i18.2535","article-title":"Portal hypertension due to portal venous thrombosis: etiology, clinical outcomes","volume":"13","author":"Harmanci","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.esmoop.2023.101200_bib35","article-title":"ALBI grade: evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma","volume":"3","author":"Demirtas","year":"2021","journal-title":"JHEP Rep"},{"issue":"1","key":"10.1016\/j.esmoop.2023.101200_bib37","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s12029-016-9873-x","article-title":"A\u00a0novel combination of C-reactive protein and vascular endothelial growth factor in differential diagnosis of ascites","volume":"48","author":"Abdel-Razik","year":"2017","journal-title":"J\u00a0Gastrointest Cancer"},{"key":"10.1016\/j.esmoop.2023.101200_bib38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejca.2016.05.004","article-title":"Intraperitoneal bevacizumab for control of malignant ascites due to advanced-stage gastrointestinal cancers: a multicentre double-blind, placebo-controlled phase II study - AIO SUP-0108","volume":"63","author":"Jordan","year":"2016","journal-title":"Eur J Cancer"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702923004234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702923004234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:30:40Z","timestamp":1761856240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702923004234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S2059702923004234"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2023.101200","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical risk factors for ascites in metastatic pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2023.101200","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101200"}}